Freemont Management’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-8,600
| Closed | -$708K | – | 80 |
|
|
2024
Q2 | $708K | Sell |
8,600
-42,300
| -83% | -$3.48M | 0.33% | 60 |
|
|
2024
Q1 | $4.45M | Sell |
50,900
-15,800
| -24% | -$1.38M | 0.63% | 49 |
|
|
2023
Q4 | $6.43M | Hold |
66,700
| – | – | 0.81% | 41 |
|
|
2023
Q3 | $5.9M | Sell |
66,700
-11,300
| -14% | -$1,000K | 0.88% | 39 |
|
|
2023
Q2 | $6.76M | Buy |
+78,000
| New | +$6.76M | 0.82% | 43 |
|